The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Global Health Ltd

Global Health Ltd

BSE 543654 · NSE MEDANTA · ISIN INE474Q01031 · Group A · Active

Healthcare › Healthcare › Healthcare Services › Hospital

₹1,470.50

-2.78%

BSE close, 28 August 2026

Market cap

₹39,537.60 cr

26.9 cr shares · Mid cap

Free float

₹12,998.14 cr

as published

P/E · P/B

82.1× · 12.97×

EPS ₹17.91 · BV ₹113.38

FY25-26 rev / PAT

3,709.38 / 496.20

₹ cr, as filed

Filings, window

38

8 selected · 21%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹955.20 52-WK HIGH ₹1,542.00 ₹1,470.50 88% of range
Against 52-week high-4.6%
Against 52-week low+53.9%
Day change-2.78%
Size bandMid cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹17.91
Price / earnings82.10×
Price / book12.97×
Book value — derived, price ÷ P/B₹113.38
Return on equity15.80%
Operating margin23.51%
Net margin12.73%

Consistency check

P/B ÷ P/E, which must equal ROE
15.80%
ROE as published
15.80%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 1,078.72 137.31 5.11 23.51% 12.73%
Mar-26 · Q 960.63 124.13 4.62 23.85% 12.92%
FY25-26 3,709.38 496.20 18.46 23.23% 13.38%

Quarter on quarter

Revenue, quarter on quarter
+12.3%
Net profit, quarter on quarter
+10.6%
Operating margin, quarter on quarter
-34 bps

Disclosure profile 38 filings in the window

0 median 17.0 p75 · 25 sector max 52 38 97th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

38 filings · 8 selected · busiest 2026-07-30

Filing rhythm · the twelve most recent

2026-09-102026-10-05

SelectedProcedural

Filings

38 in the window · 16 earlier on record

  1. 5 October 2026 ·

    General

    Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating Assigned By Crisil ESG Ratings & Analytics Limited.

    Intimation Under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating assigned by Crisil ESG Ratings & Analytics Limited.

    Company Update / General View filing →

  2. 29 September 2026 ·

    Press Release

    Press Release / Media Release

    Medanta to expand Healthcare Footprint in Uttar Pradesh with the Acquisition of 10,560 Sq. Meter Land Parcel in Ghaziabad.

    Company Update / Press Release / Media Release View filing →

  3. 28 September 2026 ·

    General

    Intimation Under Regulation 30 Of The Listing Regulations.

    Intimation Under Regulation 30 of Listing Regulations.

    Company Update / General View filing →

  4. 24 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation regarding closure of Trading Window for the Second Quarter ended on September 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 22 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  6. 22 September 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Intimation under Regulation 30 of Listing Regulations regarding allotment of shares.

    Company Update / Allotment of ESOP / ESPS View filing →

  7. 17 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  8. 16 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Enclosed Scrutinizer Report and Voting Results of 22nd Annual General Meeting of the Company.

    AGM/EGM / AGM View filing →

  9. 16 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceeding of 22nd Annual General Meeting of the Company held on September 16, 2026, at 12:00 Noon.

    AGM/EGM / AGM View filing →

  10. 11 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  11. 11 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  12. 10 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  13. 9 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  14. 3 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  15. 3 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  16. 31 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  17. 31 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  18. 25 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

    Company Update / Analyst / Investor Meet View filing →

  19. 21 August 2026 ·

    General

    Letter To Shareholders Providing The Weblink Of Annual Report For The FY 2025-26

    Enclosed.

    Company Update / General View filing →

  20. 21 August 2026 ·

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Business Responsibility and Sustainability Report along with Assurance Report for the Financial Year 2025-26.

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  21. 21 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Please find enclosed herewith the Annual Report along with BRSR and AGM Notice for Financial Year 2025-26.

    Others / Reg. 34 (1) Annual Report View filing →

  22. 21 August 2026 ·

    AGM / EGM

    Notice Of 22Nd Annual General Meeting Scheduled To Be Held On Wednesday, September 16, 2026 Through Video Conferencing (VC)/ OAVM For The Financial Year 2025-26.

    Enclosed

    AGM/EGM / AGM View filing →

  23. 18 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Announcement under SEBI Listing Regulations regarding Schedule of Analyst Meet.

    Company Update / Analyst / Investor Meet View filing →

  24. 12 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Copy of Pre-advertisement of Annual General Meeting 2026.

    Company Update / Newspaper Publication View filing →

  25. 5 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Announcement under Regulation 30 of Listing Regulations,2015 for Earning Conference call Transcript.

    Company Update / Earnings Call Transcript View filing →

  26. 31 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Intimation under Regulation 30 of SEBI Listing Regulations 2015- Audio Recording.

    Company Update / Analyst / Investor Meet View filing →

  27. 31 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication under Regulation 30 and 47 of SEBI Listing Regulations.

    Company Update / Newspaper Publication View filing →

  28. 31 July 2026 ·

    Dividend

    Date of payment of Dividend

    Intimation under Regulation 30 of Listing Regulations regarding Dividend.

    Corp Action / Date of payment of Dividend View filing →

  29. 30 July 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation for First Quarter ended on June 30, 2026, Results of the Company.

    Company Update / Investor Presentation View filing →

  30. 30 July 2026 ·

    Press Release

    Press Release / Media Release

    Press Release for the First Quarter ended June 30, 2026, Results

    Company Update / Press Release / Media Release View filing →

  31. 30 July 2026 ·

    Meeting Update

    Meeting Updates

    Board Meeting Intimation under Regulation 30 of Listing Regulations regarding the Capacity Addition.

    Company Update / Meeting Updates View filing →

  32. 30 July 2026 ·

    Record Date

    Fixation Of Records Date For Declaration Of Dividend.

    It is informed that Company has fixed August 14, 2026, as Record Date for the declaration of Dividend.

    Corp. Action / Record Date View filing →

  33. 30 July 2026 ·

    Results

    Result For The Quarter Ended June 30, 2026

    Result for the Quarter ended June 30, 2026

    Result / Financial Results View filing →

  34. 30 July 2026 ·

    Change in Management

    Change in Management

    Announcement regarding appointment of Mr. Pradeep Kumar Singh as one of the Senior Management Personnel.

    Company Update / Change in Management View filing →

  35. 30 July 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.

    Outcome of Board Meeting held today i.e. July 30, 2026, to consider Unaudited Financial Results for Quarter ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  36. 30 July 2026 ·

    Meeting Update

    Meeting Updates

    It is informed that the Nomination & Remuneration Committee in its Meeting held on July 30, 2026, has made a grant of 20,000 ESOPs under GHL LTIP 2024

    Company Update / Meeting Updates View filing →

  37. 24 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation for Earning Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

    Company Update / Analyst / Investor Meet View filing →

  38. 20 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Schedule Of Board Meeting For The First Quarter Ended June 30, 2026, Under Regulation 29 Of Listing Regulations.

    Global Health Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....

    Board Meeting / Board Meeting View filing →

RSS feed for Global Health Ltd · the 50 most recent filings